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ABSTRACT 
BACKGROUND: 
Non alcoholic fatty liver disease (NAFLD) is one of the  common causes 
for chronic liver disease. NAFLD is diagnosed when daily alcohol consumption 
is≤30 g/ day in men and ≤20 g/day in women and with exclusion of other causes 
of fatty liver such as viral hepatitis autoimmune hepatitis, steatogenic drugs, 
etc.It is widely known that increased serum uric acid levels often co-exist with 
insulin resistance, obesity. Inflammation and oxidative stress are hypothesized 
to be the essential link in this relationship. Recently, several observational 
studies suggest that hyperuricemia (serum uric acid (SUA) level>7.0 mg/dL in 
men and >5.7 mg/dL in women) is a risk factor for NAFLD among eastern 
Asian populations independent of the components of metabolic syndrome 
Hence, this study done to find the association between serum uric acid and 
newly diagnosed NAFLD patients and to find its correlation with liver fibrosis 
which is assessed by Fibroscan. 
AIMS & OBJECTIVE 
To determine the association between ultrasound defined NAFLD and 
serum uric acid and to find the correlation between serum uric acid level 
and severity of NAFLD by assessment of liver fibrosis by Fibroscan 
MATERIALS AND METHODS 
SETTING: Department of General medicine and Govt Rajaji hospital 
DESIGN OF STUDY: Prospective case control study DURATION OF 
STUDY: March 2018 to August 2018.INCLUSION CRITERIA: All newly 
diagnosed cases of ultrasound defined NAFLD within age group of 25 to 65. 
EXCLUSION CRITERIA: Patients with alcohol consumption greater than 
20gm/day in men & 10gm/day in women, HBsAg & Anti HCV positivity, 
Patients with history of chronic liver disease, coronary artery disease, chronic 
kidney disease, patients on diuretics, anti gout medications, anti retroviral 
therapy were excluded from the study. METHOD: 100 NAFLD case and 100 
age and sex matched controls were selected based on inclusion/exclusion 
criteria. Clinical examination and relevant investigations  such as FBS, ALT, 
AST, BMI, fasting triglycerides, systolic BP, Serum uric acid , fibroscan were 
done. The values are plotted in excel sheet & statistical analysis is done by One 
way ANOVA test and chi square test  
RESULTS 
Both in cases and controls, most of them were in age group of 46 to 55 
years of age. There was a  higher incidence of NAFLD in males (56%) when 
compared with females (44%) in our study. The mean ALT level in our cases is 
34.44 U/L while it is 30.39 U/L in control group. The mean AST level in 
NAFLD cases is 35.81 U/L while in the control group, the mean valve is 34.28  
U/L. There is a statistical significance between AST & ALT values (p<0.05) 
between cases and controls. The mean triglycerides level in NAFLD case is 
184.19 mg/dL while it is 162.03mg/dL in control group. . The mean BMI in 
NAFLD cases is 24.46 kg/m2 while it is 23.63 kg/m2 in control group which 
again shows statistical significance (p<0.05) between two groups The mean 
FBS in case group is 93.86 mg/dL & the mean FBS value in control group is 
88.03mg/dL. . The mean systolic BP in case group is 121.42mmHg while it is 
116.52mmHg in control group. Again, there is a statistical significance of 
triglyceride level, FBS, BMI, SBP values between cases and control. This might 
indicate increase in prevalence of metabolic syndrome in NAFLD cases.   
The mean serum uric acid levels in NAFLD cases is 6.43 mg/dL while it 
is 5.45mg/dL in control. In males, the mean serum uric acid level is 6.959 
mg/dL in NAFLD cases while it is 5.875 in control group.  In females, the mean 
serum uric acid level is 5.75 mg/dL while it is 4.93 in control group. There is 
high statistical significance (p<0.001) between cases and controls in all the 
above values. Hence our study shows there is higher prevalence of 
hyperuricemia in NAFLD cases in both males & females. In 100 NAFLD 
patients, Fibroscan was done and the Liver stiffness value > 7 kPa was taken as 
a cut off value for fibrosis. The association between hyperuricemia and fibrosis 
is assessed by chi- square test. The chi square value is 4.127 and the p value is 
0.042 (p<0.05) which is statistically significant. 
CONCLUSION 
This study shows significant correlation between serum uric acid & 
NAFLD .Hence, this study shows that presence of hyperuricemia should 
alert the possibility of underlying non alcoholic fatty liver disease if 
significant alcohol consumption is ruled out.Several studies also supports 
this association. Also there is linear association between hyperuricemia and 
presence of liver fibrosis as assessed by fibroscan. Hence uric acid levels 
play a vital role in detection of NAFLD and its the severity. However further 
studies are needed to define this association 
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